Tag: Liberia
This infographic compares the average heights of men and women across the globe, ranking the top 10 tallest and bottom 10 shortest countries. Explore how genetics, nutrition, and socioeconomic factors shape these differences—and which nations have seen the most dramatic changes over time. From towering averages in Northern Europe to shorter statures in parts of Asia and Africa, discover the trends defining human height worldwide.
When it comes to appointing foreign citizens to high government posts, conservative governments are at the forefront of “global governance.”
…No matter of the virus is of natural origin or artificially produced, there are reasons to surmise that some states and the international organizations they control, as well as obedient media outlets, act in the capacity of pharmaceutical companies’ agents. The ballyhoo raised around Ebola is viewed as an attempt to expand the market for vaccine to make it profitable or even super profitable in case a number of countries become dependent on it. If the anti-Ebola vaccine trade expands, it’ll become an issue of the state policy agenda. But the right term to use will be racket, not trade. Or a special operation… The sad thing about it is that the ongoing special operation is really merciless – no one can refuse the service offered. It cannot be excluded that the Ebola virus is an element of policy aimed at world destabilization, something the United States is doing today and, at the same time, a new form of unleashing a multi-level crisis when the medicine would be available only for the «chosen».
The US Department of Defense (DoD) is funding Ebola trials on humans, trials which started just weeks before the Ebola outbreak in Guinea and Sierra Leone. The reports continue and state that the DoD gave a contract worth $140 million dollars to Tekmira, a Canadian pharmaceutical company, to conduct Ebola research. This research work involved injecting and infusing healthy humans with the deadly Ebola virus. Hence, the DoD is listed as a collaborator in a “First in Human” Ebola clinical trial (NCT02041715, which started in January 2014 shortly before an Ebola epidemic was declared in West Africa in March.